Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 174

1.

Long-term natural history of neurofibromatosis Type 2-associated intracranial tumors.

Dirks MS, Butman JA, Kim HJ, Wu T, Morgan K, Tran AP, Lonser RR, Asthagiri AR.

J Neurosurg. 2012 Jul;117(1):109-17. doi: 10.3171/2012.3.JNS111649.

2.

Pediatric cerebellopontine angle and internal auditory canal tumors: clinical article..

Holman MA, Schmitt WR, Carlson ML, Driscoll CL, Beatty CW, Link MJ.

J Neurosurg Pediatr. 2013 Oct;12(4):317-24. doi: 10.3171/2013.6.PEDS1383.

PMID:
23909617
3.

Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium.

Fisher LM, Doherty JK, Lev MH, Slattery WH.

Otol Neurotol. 2009 Sep;30(6):835-41. doi: 10.1097/MAO.0b013e3181b2364c.

PMID:
19704365
4.

Long-term follow-up studies of Gamma Knife surgery for patients with neurofibromatosis Type 2.

Sun S, Liu A.

J Neurosurg. 2014 Dec;121 Suppl:143-9. doi: 10.3171/2014.8.GKS141503.

PMID:
25434947
5.

Distribution of nonvestibular cranial nerve schwannomas in neurofibromatosis 2.

Fisher LM, Doherty JK, Lev MH, Slattery WH 3rd.

Otol Neurotol. 2007 Dec;28(8):1083-90. Erratum in: Otol Neurotol. 2008 Sep;29(6):885.

PMID:
18043434
6.

Unilateral vestibular schwannoma with other neurofibromatosis type 2-related tumors: clinical and molecular study of a unique phenotype.

Aghi M, Kluwe L, Webster MT, Jacoby LB, Barker FG 2nd, Ojemann RG, Mautner VF, MacCollin M.

J Neurosurg. 2006 Feb;104(2):201-7.

PMID:
16509493
7.

Factors influencing the growth rate of vestibular schwannoma in patients with neurofibromatosis type 2.

Li H, Hao SY, Wang L, Li D, Wu Z, Zhang LW, Zhang JT.

Acta Neurochir (Wien). 2015 Nov;157(11):1983-90. doi: 10.1007/s00701-015-2542-1.

PMID:
26287269
8.

Clinical course and management of intracranial meningiomas in neurofibromatosis type 2 patients.

Nowak A, Dziedzic T, Czernicki T, Kunert P, Marchel A.

Neurol Neurochir Pol. 2015;49(6):367-72. doi: 10.1016/j.pjnns.2015.08.007.

PMID:
26652870
9.

Intracranial meningiomas and neurofibromatosis type 2.

Aboukais R, Zairi F, Baroncini M, Bonne NX, Schapira S, Vincent C, Lejeune JP.

Acta Neurochir (Wien). 2013 Jun;155(6):997-1001; discussion 1001. doi: 10.1007/s00701-013-1692-2.

PMID:
23558725
10.

Vestibular schwannoma growth rates in neurofibromatosis type 2 natural history consortium subjects.

Slattery WH 3rd, Fisher LM, Iqbal Z, Oppenhiemer M.

Otol Neurotol. 2004 Sep;25(5):811-7.

PMID:
15354016
11.

Clinical course of vestibular schwannoma in pediatric neurofibromatosis Type 2.

Choi JW, Lee JY, Phi JH, Wang KC, Chung HT, Paek SH, Kim DG, Park SH, Kim SK.

J Neurosurg Pediatr. 2014 Jun;13(6):650-7. doi: 10.3171/2014.3.PEDS13455.

PMID:
24724714
12.

Multiple schwannomas: schwannomatosis or neurofibromatosis type 2?

Seppälä MT, Sainio MA, Haltia MJ, Kinnunen JJ, Setälä KH, Jääskeläinen JE.

J Neurosurg. 1998 Jul;89(1):36-41.

PMID:
9647170
13.

Bevacizumab treatment for meningiomas in NF2: a retrospective analysis of 15 patients.

Nunes FP, Merker VL, Jennings D, Caruso PA, di Tomaso E, Muzikansky A, Barker FG 2nd, Stemmer-Rachamimov A, Plotkin SR.

PLoS One. 2013;8(3):e59941. doi: 10.1371/journal.pone.0059941.

14.

Predictors of vestibular schwannoma growth in patients with neurofibromatosis Type 2.

Baser ME, Makariou EV, Parry DM.

J Neurosurg. 2002 Feb;96(2):217-22.

PMID:
11838793
15.

Vestibular schwannoma growth in patients with neurofibromatosis Type 2: a longitudinal study.

Mautner VF, Baser ME, Thakkar SD, Feigen UM, Friedman JM, Kluwe L.

J Neurosurg. 2002 Feb;96(2):223-8.

PMID:
11838794
16.

Neurofibromatosis type 2.

Slattery WH.

Otolaryngol Clin North Am. 2015 Jun;48(3):443-60. doi: 10.1016/j.otc.2015.02.005. Review.

PMID:
26043141
17.

Growth Dynamics of Intracranial Tumors in Patients with Neurofibromatosis Type 2.

Lawson McLean AC, Rosahl SK.

World Neurosurg. 2016 Oct 21. pii: S1878-8750(16)31049-X. doi: 10.1016/j.wneu.2016.10.060. [Epub ahead of print]

PMID:
27777160
18.

Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas.

Antinheimo J, Sankila R, Carpén O, Pukkala E, Sainio M, Jääskeläinen J.

Neurology. 2000 Jan 11;54(1):71-6.

PMID:
10636128
19.

Stereotactic radiosurgery for neurofibromatosis 2-associated vestibular schwannomas: toward dose optimization for tumor control and functional outcomes.

Mallory GW, Pollock BE, Foote RL, Carlson ML, Driscoll CL, Link MJ.

Neurosurgery. 2014 Mar;74(3):292-300; discussion 300-1. doi: 10.1227/NEU.0000000000000264.

PMID:
24335819
20.

Prognostic value and management of spinal tumors in neurofibromatosis type 2 patients.

Aboukais R, Baroncini M, Zairi F, Bonne NX, Schapira S, Vincent C, Lejeune JP.

Acta Neurochir (Wien). 2013 May;155(5):771-7. doi: 10.1007/s00701-012-1590-z.

PMID:
23381342
Items per page

Supplemental Content

Support Center